These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7756397)

  • 21. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A total subcutaneously implantable venous catheter system. 4 years' experience in cancer patients].
    Ludwig R; Ludwig CU; Laffer U; Stoll HR; Obrecht JP
    Schweiz Med Wochenschr; 1988 Mar; 118(9):305-8. PubMed ID: 3358106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous access in newborn infants: impact of extended umbilical venous catheter use on requirement for peripheral venous lines.
    Loisel DB; Smith MM; MacDonald MG; Martin GR
    J Perinatol; 1996; 16(6):461-6. PubMed ID: 8979185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New implantable device for long-term vascular access in children.
    Reinberg O; Beck D
    Eur J Pediatr Surg; 1992 Jun; 2(3):183-5. PubMed ID: 1498114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new system for permanent venous access, Cathlink 20: prospective clinical study. 95 cases].
    Lakdja F; Roubault N; Fonrouge JM
    Pathol Biol (Paris); 1999 Mar; 47(3):273-8. PubMed ID: 10214622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chest port placement with use of the single-incision insertion technique.
    Charles HW; Miguel T; Kovacs S; Gohari A; Arampulikan J; McCann JW
    J Vasc Interv Radiol; 2009 Nov; 20(11):1464-9. PubMed ID: 19875065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fully implantable catheter systems. Long-term results--complications].
    Wenke K; Markewitz A
    Fortschr Med; 1990 May; 108(14):276-9. PubMed ID: 2115492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Venous access devices in oncology].
    Maňásek V; Soumarová R; Kociánová I; Maňásková M
    Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medial venous catheter or midline (MVC)].
    Carrero Caballero MC; Montealegre Sanz M; Cubero Pérez MA
    Rev Enferm; 2014 Jan; 37(1):36-41. PubMed ID: 24624619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an implantable venous access system in a general oncology population.
    Barrios CH; Zuke JE; Blaes B; Hirsch JD; Lyss AP
    Oncology; 1992; 49(6):474-8. PubMed ID: 1465287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a polymer implanted port access device.
    Brown JM
    J Intraven Nurs; 1996; 19(6):303-6. PubMed ID: 9060356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Totally implantable venous access ports by cephalic vein cut-down for patients receiving chemotherapy].
    Ayadi S; Ksantini R; Maghrebi H; Daghfous A; Ayadi M; Fteriche F; Bedioui H; Chebbi F; Amous A; Jouini M; Kacem M; Mezlini A; Ben Safta Z
    Tunis Med; 2011; 89(8-9):699-702. PubMed ID: 21948685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrin sleeve formation after long term brachial catheterisation with an implantable port device. A prospective venographic study.
    Starkhammar H; Bengtsson M; Morales O
    Eur J Surg; 1992 Sep; 158(9):481-4. PubMed ID: 1358215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.
    Bow EJ; Kilpatrick MG; Clinch JJ
    J Clin Oncol; 1999 Apr; 17(4):1267. PubMed ID: 10561188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of radiologic placement of a central vein access device.
    Beheshti MV; Protzer WR; Tomlinson TL; Martinek E; Baatz LA; Collins MS
    AJR Am J Roentgenol; 1998 Mar; 170(3):731-4. PubMed ID: 9490964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases.
    Groebli Y; Wutrich P; Safa M; Tschantz P; Callewaert G; Piguet D
    Panminerva Med; 1999 Jun; 41(2):89-92. PubMed ID: 10479903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved methods in long term venous access using the P.A.S. Port.
    Pearl JM; Goldstein L; Ciresi KF
    Surg Gynecol Obstet; 1991 Oct; 173(4):313-5. PubMed ID: 1925903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.